BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36562381)

  • 1. Identification of antibody against wingless‑type MMTV integration site family member 7B as a biliary cancer tumor marker.
    Takahashi M; Tsuchikawa T; Hiwasa T; Nakamura T; Hontani K; Kushibiki T; Inoko K; Takano H; Hatanaka Y; Matsushita K; Matsubara H; Hoshino T; Ohtsuka M; Shimada H; Tanaka K; Nakanishi Y; Asano T; Noji T; Okamura K; Shichinohe T; Hirano S
    Oncol Rep; 2023 Feb; 49(2):. PubMed ID: 36562381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of serum anti-striatin 4 antibodies as a common marker for esophageal cancer and other solid cancers.
    Ito M; Hiwasa T; Oshima Y; Yajima S; Suzuki T; Nanami T; Sumazaki M; Shiratori F; Funahashi K; Takizawa H; Kashiwado K; Tochigi N; Shimada H
    Mol Clin Oncol; 2021 Nov; 15(5):237. PubMed ID: 34650804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum anti-LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases.
    Sumazaki M; Shimada H; Ito M; Shiratori F; Kobayashi E; Yoshida Y; Adachi A; Matsutani T; Iwadate Y; Mine S; Machida T; Kamitsukasa I; Mori M; Sugimoto K; Uzawa A; Kuwabara S; Kobayashi Y; Ohno M; Nishi E; Maezawa Y; Takemoto M; Yokote K; Takizawa H; Kashiwado K; Shin H; Kishimoto T; Matsushita K; Kobayashi S; Nakamura R; Shinmen N; Kuroda H; Zhang XM; Wang H; Goto KI; Hiwasa T
    Cancer Sci; 2020 Dec; 111(12):4453-4464. PubMed ID: 32939876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of specific and common diagnostic antibody markers for gastrointestinal cancers by SEREX screening using testis cDNA phage library.
    Kobayashi S; Hiwasa T; Arasawa T; Kagaya A; Ishii S; Shimada H; Ito M; Suzuki M; Kano M; Rahmutulla B; Kitamura K; Sawabe Y; Shin H; Takiguchi M; Nomura F; Matsubara H; Matsushita K
    Oncotarget; 2018 Apr; 9(26):18559-18569. PubMed ID: 29719626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus.
    Namiki T; Takemoto M; Hayashi A; Yamagata H; Ishikawa T; Yokote K; Li SY; Kubota M; Zhang BS; Yoshida Y; Matsutani T; Mine S; Machida T; Kobayashi Y; Terada J; Naito A; Tatsumi K; Takizawa H; Nakamura R; Kuroda H; Iwadate Y; Hiwasa T
    BMC Endocr Disord; 2023 Oct; 23(1):239. PubMed ID: 37904164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of HCC-22-5 tumor-associated antigen and antibody response in patients.
    Zhou SF; Xie XX; Bin YH; Lan L; Chen F; Luo GR
    Clin Chim Acta; 2006 Apr; 366(1-2):274-80. PubMed ID: 16356486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Makorin 1 as a novel SEREX antigen of esophageal squamous cell carcinoma.
    Shimada H; Shiratori T; Yasuraoka M; Kagaya A; Kuboshima M; Nomura F; Takiguchi M; Ochiai T; Matsubara H; Hiwasa T
    BMC Cancer; 2009 Jul; 9():232. PubMed ID: 19604354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers.
    Kojima M; Sudo H; Kawauchi J; Takizawa S; Kondou S; Nobumasa H; Ochiai A
    PLoS One; 2015; 10(2):e0118220. PubMed ID: 25706130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between serum anti‑ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension.
    Li SY; Yoshida Y; Kobayashi E; Adachi A; Hirono S; Matsutani T; Mine S; Machida T; Ohno M; Nishi E; Maezawa Y; Takemoto M; Yokote K; Kitamura K; Sumazaki M; Ito M; Shimada H; Takizawa H; Kashiwado K; Tomiyoshi G; Shinmen N; Nakamura R; Kuroda H; Zhang XM; Wang H; Goto K; Iwadate Y; Hiwasa T
    Int J Mol Med; 2020 Oct; 46(4):1274-1288. PubMed ID: 32945427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer.
    Ito M; Hiwasa T; Oshima Y; Yajima S; Suzuki T; Nanami T; Sumazaki M; Shiratori F; Funahashi K; Li SY; Iwadate Y; Yamagata H; Jambaljav B; Takemoto M; Yokote K; Takizawa H; Shimada H
    Front Oncol; 2021; 11():708039. PubMed ID: 34504788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel SEREX antigen family, ECSA, in esophageal squamous cell carcinoma.
    Kagaya A; Shimada H; Shiratori T; Kuboshima M; Nakashima-Fujita K; Yasuraoka M; Nishimori T; Kurei S; Hachiya T; Murakami A; Tamura Y; Nomura F; Ochiai T; Matsubara H; Takiguchi M; Hiwasa T
    Proteome Sci; 2011 Jun; 9(1):31. PubMed ID: 21696638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of anti-CUEC-23 antibodies in serum of patients with esophageal squamous cell carcinoma: a possible new serum marker for esophageal cancer.
    Shimada H; Kagaya A; Shiratori T; Nomura F; Takiguchi M; Matsubara H; Hiwasa T
    J Gastroenterol; 2009; 44(7):691-6. PubMed ID: 19407926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and humoral immune responses to a human pancreatic cancer antigen, coactosin-like protein, originally defined by the SEREX method.
    Nakatsura T; Senju S; Ito M; Nishimura Y; Itoh K
    Eur J Immunol; 2002 Mar; 32(3):826-36. PubMed ID: 11870627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-specific immunological recognition of frameshift-mutated peptides in colon cancer with microsatellite instability.
    Ishikawa T; Fujita T; Suzuki Y; Okabe S; Yuasa Y; Iwai T; Kawakami Y
    Cancer Res; 2003 Sep; 63(17):5564-72. PubMed ID: 14500396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction.
    Wang H; Zhang XM; Tomiyoshi G; Nakamura R; Shinmen N; Kuroda H; Kimura R; Mine S; Kamitsukasa I; Wada T; Aotsuka A; Yoshida Y; Kobayashi E; Matsutani T; Iwadate Y; Sugimoto K; Mori M; Uzawa A; Muto M; Kuwabara S; Takemoto M; Kobayashi K; Kawamura H; Ishibashi R; Yokote K; Ohno M; Chen PM; Nishi E; Ono K; Kimura T; Machida T; Takizawa H; Kashiwado K; Shimada H; Ito M; Goto KI; Iwase K; Ashino H; Taira A; Arita E; Takiguchi M; Hiwasa T
    Oncotarget; 2018 Jan; 9(5):5600-5613. PubMed ID: 29464021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological identification of tumor antigens of esophageal squamous cell carcinoma.
    Shimada H; Nakashima K; Ochiai T; Nabeya Y; Takiguchi M; Nomura F; Hiwasa T
    Int J Oncol; 2005 Jan; 26(1):77-86. PubMed ID: 15586227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potential biomarkers for diagnosis of pancreatic and biliary tract cancers by sequencing of serum microRNAs.
    Kim K; Yoo D; Lee HS; Lee KJ; Park SB; Kim C; Jo JH; Jung DE; Song SY
    BMC Med Genomics; 2019 May; 12(1):62. PubMed ID: 31096984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against p53 protein in serum of patients with benign or malignant pancreatic and biliary diseases.
    Laurent-Puig P; Lubin R; Semhoun-Ducloux S; Pelletier G; Fourre C; Ducreux M; Briantais MJ; Buffet C; Soussi T
    Gut; 1995 Mar; 36(3):455-8. PubMed ID: 7698709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers.
    Letelier P; Riquelme I; Hernández AH; Guzmán N; Farías JG; Roa JC
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27223281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tumor markers for pancreatic and biliary tract cancer].
    Takezako Y; Okusaka T; Ueno H; Ikeda M; Morizane C; Najima M
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1443-6. PubMed ID: 15446574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.